PYRAZOLOPYRIMIDINES AS THERAPEUTIC AGENTS

摘要

The present invention provides compounds of Formula I, including pharmaceutically acceptable salts and/or prodrugs thereof, where G, Ra, R2, and R3 are defined as described herein.